A device that acts as an artificial pancreas was better in managing blood sugar levels among type 2 diabetics compared with manually getting insulin، a new study reveals، as Technical Times said.
The device، variations of which have been used previously to treat type 1 diabetics، more consistently kept blood sugar levels of type 2 diabetics within the target zone than the control group. Experts argue this technology could help improve health outcomes and ultimately reduce trips to the doctor for management of blood sugar levels. That's crucial because when diabetes isn't managed well، high blood sugar levels can extend hospital stays and increase the risk of complications and even death، according to the researchers.
The artificial pancreas in question is an automated insulin pump that doubles as a glucose monitor. It's still new and is more commonly used among type 1 diabetics — patients who must be given multiple shots of insulin every day to avoid complications.
The study is the first to test the device among type 2 diabetics outside a critical setting، said study author Roman Hovorka، research director at University of Cambridge's Metabolic Research Laboratories.
The findings were published June 25 in the New England Journal of Medicine.
Artificial Pancreas Pumps Insulin Automatically According to Hovorka، the artificial pancreas was able to "considerably" improve blood sugar control and didn't increase the risk of hypoglycemia، or low blood sugar level for in-patients requiring insulin on the general ward.